(-)-alpha-phellandrene increases expression ISO RGD:1354251 6480464 alpha phellandrene results in increased expression of GBP6 mRNA CTD PMID:25075043 (2,4,5-trichlorophenoxy)acetic acid increases expression ISO RGD:1614157 6480464 2 more ... CTD PMID:18579281 1,2-dichloroethane decreases expression ISO RGD:1614157 6480464 ethylene dichloride results in decreased expression of GBP6 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine increases expression ISO RGD:1614157 6480464 1 more ... CTD PMID:22206623 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of GBP6 mRNA, [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GBP6 mRNA CTD PMID:26496021 , PMID:32741896 17beta-estradiol multiple interactions ISO RGD:1354251 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of GBP6 mRNA CTD PMID:30165855 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GBP6 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of GBP6 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1614157 6480464 Tetrachlorodibenzodioxin results in decreased expression of GBP6 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1614157 6480464 Tetrachlorodibenzodioxin affects the expression of GBP6 mRNA CTD PMID:26377647 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1614157 6480464 Tetrachlorodibenzodioxin results in increased expression of GBP6 mRNA CTD PMID:19933214 2-hydroxypropanoic acid decreases expression ISO RGD:1354251 6480464 Lactic Acid results in decreased expression of GBP6 mRNA CTD PMID:30851411 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1354251 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GBP6 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of GBP6 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:1614157 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of GBP6 mRNA, bis(4-hydroxyphenyl)sulfone results in increased expression of GBP9 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:1614157 6480464 Fenretinide results in decreased expression of GBP6 mRNA CTD PMID:28973697 aflatoxin B1 decreases methylation ISO RGD:1354251 6480464 Aflatoxin B1 results in decreased methylation of GBP6 gene CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:1614157 6480464 Aflatoxin B1 results in increased expression of GBP6 mRNA CTD PMID:19770486 aldrin increases expression ISO RGD:1614157 6480464 Aldrin results in increased expression of GBP9 mRNA CTD PMID:18579281 alpha-phellandrene increases expression ISO RGD:1354251 6480464 alpha phellandrene results in increased expression of GBP6 mRNA CTD PMID:25075043 antirheumatic drug decreases expression ISO RGD:1354251 6480464 Antirheumatic Agents results in decreased expression of GBP6 mRNA CTD PMID:24449571 arsane affects methylation ISO RGD:1354251 6480464 Arsenic affects the methylation of GBP6 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1354251 6480464 Arsenic affects the methylation of GBP6 gene CTD PMID:25304211 benzo[a]pyrene decreases methylation ISO RGD:1354251 6480464 Benzo(a)pyrene results in decreased methylation of GBP6 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1614157 6480464 Benzo(a)pyrene results in increased expression of GBP6 mRNA CTD PMID:23735875 benzo[a]pyrene decreases expression ISO RGD:1614157 6480464 Benzo(a)pyrene results in decreased expression of GBP6 mRNA, Benzo(a)pyrene results in decreased expression of GBP9 mRNA CTD PMID:19770486 more ... benzo[a]pyrene increases methylation ISO RGD:1354251 6480464 Benzo(a)pyrene results in increased methylation of GBP6 3' UTR, Benzo(a)pyrene results in increased methylation of GBP6 5' UTR CTD PMID:27901495 beta-naphthoflavone multiple interactions ISO RGD:1614157 6480464 AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of GBP6 mRNA] CTD PMID:22234961 beta-naphthoflavone decreases expression ISO RGD:1614157 6480464 beta-Naphthoflavone results in decreased expression of GBP6 mRNA CTD PMID:22234961 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GBP6 mRNA CTD PMID:25181051 , PMID:35192832 bisphenol A increases expression ISO RGD:1614157 6480464 bisphenol A results in increased expression of GBP6 mRNA CTD PMID:30951980 bisphenol A multiple interactions ISO RGD:1354251 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GBP6 mRNA CTD PMID:28628672 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of GBP6 mRNA CTD PMID:26496021 bisphenol F multiple interactions ISO RGD:1354251 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of GBP6 mRNA CTD PMID:28628672 bisphenol F increases expression ISO RGD:1614157 6480464 bisphenol F results in increased expression of GBP6 mRNA, bisphenol F results in increased expression of GBP9 mRNA CTD PMID:30951980 buta-1,3-diene decreases expression ISO RGD:1614157 6480464 1, 3-butadiene results in decreased expression of GBP9 mRNA CTD PMID:29038090 carbon nanotube affects expression ISO RGD:1614157 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1614157 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube increases expression ISO RGD:1614157 6480464 Nanotubes more ... CTD PMID:25554681 chloroethene increases expression ISO RGD:1614157 6480464 Vinyl Chloride results in increased expression of GBP9 mRNA CTD PMID:18579281 chloroprene decreases expression ISO RGD:1614157 6480464 Chloroprene results in decreased expression of GBP6 mRNA CTD PMID:23125180 cholesterol multiple interactions ISO RGD:1614157 6480464 [Cholesterol co-treated with 1, 2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of GBP9 mRNA CTD PMID:22129739 cobalt dichloride increases expression ISO RGD:1614157 6480464 cobaltous chloride results in increased expression of GBP9 mRNA CTD PMID:21139344 copper(II) sulfate increases expression ISO RGD:1614157 6480464 Copper Sulfate results in increased expression of GBP9 mRNA CTD PMID:18579281 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of GBP6 mRNA CTD PMID:27523638 dexamethasone multiple interactions ISO RGD:1354251 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GBP6 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of GBP6 mRNA CTD PMID:28628672 dextran sulfate increases expression ISO RGD:1614157 6480464 Dextran Sulfate results in increased expression of GBP9 protein CTD PMID:32272095 dextran sulfate multiple interactions ISO RGD:1614157 6480464 Erianin inhibits the reaction [Dextran Sulfate results in increased expression of GBP9 protein] CTD PMID:32272095 dibenz[a,h]anthracene increases expression ISO RGD:1614157 6480464 1 more ... CTD PMID:26377693 dichloroacetic acid decreases expression ISO RGD:1614157 6480464 Dichloroacetic Acid results in decreased expression of GBP6 mRNA CTD PMID:28962523 dimethylarsinic acid multiple interactions ISO RGD:1614157 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GBP9 mRNA CTD PMID:34876320 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GBP6 mRNA CTD PMID:33729688 dioxygen multiple interactions ISO RGD:1614157 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GBP6 mRNA CTD PMID:30529165 doxorubicin multiple interactions ISO RGD:1614157 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of GBP6 mRNA CTD PMID:21040762 doxorubicin decreases expression ISO RGD:1614157 6480464 Doxorubicin results in decreased expression of GBP6 mRNA CTD PMID:21040762 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of GBP6 mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:1614157 6480464 epoxiconazole results in decreased expression of GBP9 mRNA CTD PMID:35436446 ethyl methanesulfonate decreases expression ISO RGD:1354251 6480464 Ethyl Methanesulfonate results in decreased expression of GBP6 mRNA CTD PMID:23649840 folic acid increases expression ISO RGD:1614157 6480464 Folic Acid results in increased expression of GBP6 mRNA CTD PMID:25629700 formaldehyde decreases expression ISO RGD:1354251 6480464 Formaldehyde results in decreased expression of GBP6 mRNA CTD PMID:23649840 graphene oxide decreases expression ISO RGD:1614157 6480464 graphene oxide results in decreased expression of GBP6 mRNA CTD PMID:33227293 GW 4064 decreases expression ISO RGD:1614157 6480464 GW 4064 results in decreased expression of GBP6 mRNA CTD PMID:26655953 indometacin multiple interactions ISO RGD:1354251 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GBP6 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of GBP6 mRNA CTD PMID:28628672 isoprenaline increases expression ISO RGD:1614157 6480464 Isoproterenol results in increased expression of GBP6 mRNA CTD PMID:20003209 lead diacetate increases expression ISO RGD:1614157 6480464 lead acetate results in increased expression of GBP6 mRNA CTD PMID:22609695 lipopolysaccharide multiple interactions ISO RGD:1354251 6480464 [S-(1 more ... CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:1354251 6480464 Lipopolysaccharides results in increased expression of GBP6 mRNA CTD PMID:35811015 methyl methanesulfonate decreases expression ISO RGD:1354251 6480464 Methyl Methanesulfonate results in decreased expression of GBP6 mRNA CTD PMID:23649840 methylarsonic acid multiple interactions ISO RGD:1614157 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GBP9 mRNA CTD PMID:34876320 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of GBP6 mRNA CTD PMID:28801915 N-nitrosodiethylamine increases expression ISO RGD:1614157 6480464 Diethylnitrosamine results in increased expression of GBP9 mRNA CTD PMID:17942915 N-nitrosodiethylamine multiple interactions ISO RGD:1614157 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of GBP9 mRNA] CTD PMID:17942915 ozone multiple interactions ISO RGD:1614157 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of GBP6 mRNA more ... CTD PMID:34911549 paracetamol increases expression ISO RGD:1354251 6480464 Acetaminophen results in increased expression of GBP6 mRNA CTD PMID:26690555 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of GBP6 mRNA CTD PMID:33387578 pentachlorophenol increases expression ISO RGD:1614157 6480464 Pentachlorophenol results in increased expression of GBP6 mRNA CTD PMID:23892564 phenobarbital increases expression ISO RGD:1614157 6480464 Phenobarbital results in increased expression of GBP6 mRNA CTD PMID:23091169 phenobarbital decreases expression ISO RGD:1614157 6480464 Phenobarbital results in decreased expression of GBP6 mRNA CTD PMID:23091169 pirinixic acid multiple interactions ISO RGD:1614157 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of GBP9 mRNA CTD PMID:20813756 pirinixic acid decreases expression ISO RGD:1614157 6480464 pirinixic acid results in decreased expression of GBP6 mRNA, pirinixic acid results in decreased expression of GBP9 mRNA CTD PMID:17426115 more ... pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1614157 6480464 Pregnenolone Carbonitrile results in decreased expression of GBP6 mRNA CTD PMID:28903501 rac-lactic acid decreases expression ISO RGD:1354251 6480464 Lactic Acid results in decreased expression of GBP6 mRNA CTD PMID:30851411 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of GBP6 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1354251 6480464 [S-(1 more ... CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:1354251 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of GBP6 mRNA CTD PMID:35811015 silicon dioxide increases expression ISO RGD:1614157 6480464 Silicon Dioxide results in increased expression of GBP6 mRNA CTD PMID:23221170 sodium arsenate multiple interactions ISO RGD:1614157 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GBP9 mRNA CTD PMID:34876320 sodium arsenite multiple interactions ISO RGD:1614157 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GBP9 mRNA CTD PMID:34876320 sodium arsenite increases expression ISO RGD:1614157 6480464 sodium arsenite results in increased expression of GBP9 mRNA CTD PMID:36209798 sodium dichromate decreases expression ISO RGD:1614157 6480464 sodium bichromate results in decreased expression of GBP6 mRNA CTD PMID:22155349 succimer multiple interactions ISO RGD:1614157 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GBP6 mRNA CTD PMID:21641980 tamoxifen affects expression ISO RGD:1614157 6480464 Tamoxifen affects the expression of GBP6 mRNA CTD PMID:20937368 tamoxifen decreases expression ISO RGD:1614157 6480464 Tamoxifen results in decreased expression of GBP6 mRNA CTD PMID:25123088 tert-butyl hydroperoxide increases expression ISO RGD:1614157 6480464 tert-Butylhydroperoxide results in increased expression of GBP6 mRNA CTD PMID:14729362 , PMID:15003993 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GBP6 mRNA CTD PMID:32741896 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of GBP6 mRNA CTD PMID:31150632 tetrachloromethane affects expression ISO RGD:1614157 6480464 Carbon Tetrachloride affects the expression of GBP6 mRNA CTD PMID:17484886 tetraphene decreases expression ISO RGD:1614157 6480464 benz(a)anthracene results in decreased expression of GBP6 mRNA CTD PMID:26377693 titanium dioxide increases expression ISO RGD:1614157 6480464 titanium dioxide results in increased expression of GBP6 mRNA CTD PMID:23557971 titanium dioxide decreases expression ISO RGD:1614157 6480464 titanium dioxide results in decreased expression of GBP6 mRNA, titanium dioxide results in decreased expression of GBP9 mRNA CTD PMID:27760801 trovafloxacin increases expression ISO RGD:1614157 6480464 trovafloxacin results in increased expression of GBP6 mRNA CTD PMID:35537566 vancomycin decreases expression ISO RGD:1614157 6480464 Vancomycin results in decreased expression of GBP6 mRNA CTD PMID:18930951 vincristine decreases expression ISO RGD:1354251 6480464 Vincristine results in decreased expression of GBP6 mRNA CTD PMID:23649840